Other diseases

Xem 1-20 trên 885 kết quả Other diseases
  • Tham khảo sách 'an account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases', khoa học xã hội, lịch sử văn hoá phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả

    pdf86p chonguoinoiay1 02-04-2013 23 2   Download

  • In writing An Atlas of Parkinson’s Disease and Related Disorders, I have been conscious of the need to find an appropriate match between the text and the illustrative material. The text is designed to provide a basic overview of the conditions discussed, inevitably concentrating on those areas which lend themselves best to photographic illustration. Some movement disorders, by their very nature, do not lend themselves to still photography whereas others, characterized by sustained postures, are ideally suited to the technique.

    pdf83p crius75 04-01-2013 25 8   Download

  • Cardiovascular disease, including coronary heart disease, strokes and diseases of other arteries, is a major cause of early death and disability. For many years the major markers of disease risk have been well recognised: these include high blood cholesterol levels and smoking. But it has also been recognised that these markers do not account for all cardiovascular risk. Furthermore, treatments that are highly effective in altering these markers, for instance the ‘statin’ drugs used to lower cholesterol, do not remove risk entirely: typically they reduce it by about 30% or less.

    pdf398p cronus75 14-01-2013 36 8   Download

  • The U.S. Preventive Services Task Force (USPSTF) provides recommendations for evidence-based screening (Table 4-3). In addition to these population-based guidelines, it is reasonable to consider family and social history to identify individuals with special risk (www.ahrq.gov/clinic/uspstfix.htm). For example, when there is a significant family history of breast, colon, or prostate cancer, it is prudent to initiate screening about 10 years before the age when the youngest family member developed cancer.

    pdf5p tubreakdance 26-11-2010 41 6   Download

  • A number of techniques can assist the physician with the growing number of recommended screening tests. An appropriately configured electronic health record can provide reminder systems that make it easier for physicians to track and meet guidelines. Some systems provide patients with secure access to their medical records, providing an additional means to enhance adherence to routine screening. Systems that provide nurses and other staff with standing orders are effective for smoking prevention and immunizations.

    pdf11p ongxaemnumber1 26-11-2010 37 6   Download

  • Host Factors in Infection For any infectious process to occur, the pathogen and the host must first encounter each other. Factors such as geography, environment, and behavior thus influence the likelihood of infection. Although the initial encounter between a susceptible host and a virulent organism frequently results in disease, some organisms can be harbored in the host for years before disease becomes clinically evident. For a complete view, individual patients must be considered in the context of the population to which they belong.

    pdf13p thanhongan 07-12-2010 47 6   Download

  • Autoimmune disease represents a group of more than 60 different chronic autoimmune diseases that affect approximately 6% of the population. It is the third major category of illness in the United States and many industrialized countries, following heart disease and cancer. Autoimmune diseases arise when one’s immune system actively targets and destroys self tissue resulting in clinical disease. Common examples include Systemic Lupus Erythematosus, Type 1 Diabetes, Rheumatoid Arthritis and Multiple Sclerosis.

    pdf401p maket1311 16-10-2012 49 6   Download

  • Neurochemical Mechanisms in Disease P2. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 33 5   Download

  • Neurochemical Mechanisms in Disease P38. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 31 5   Download

  • To date, FDA-approved for men. b May also be scarring. Exposure to various drugs can also cause diffuse hair loss, usually by inducing a telogen effluvium. An exception is the anagen effluvium observed with antimitotic agents such as daunorubicin. Alopecia is a side effect of the following drugs: warfarin, heparin, propylthiouracil, carbimazole, vitamin A, isotretinoin, acitretin, lithium, beta blockers, colchicine, and amphetamines. Fortunately, spontaneous regrowth usually follows discontinuation of the offending agent.

    pdf5p konheokonmummim 30-11-2010 25 4   Download

  • The PSA criteria used to recommend a diagnostic prostate biopsy have evolved over time. The goal is to increase the sensitivity of the test for younger men more likely to die of the disease and to reduce the frequency of detecting cancers of low malignant potential in elderly men more likely to die of other causes. Age-specific reference ranges reduce the upper limit of normal for younger men and increase it for older men. Different thresholds alter the sensitivity and specificity of detection. The threshold for performance of a biopsy was 4.0 ng/mL, which has been reduced to 2.6...

    pdf5p konheokonmummim 03-12-2010 43 4   Download

  • Metastatic Disease: Castrate Castration-resistant disease can manifest in many ways. For some it is a rise in PSA with no change in radiographs and no new symptoms. In others it is a rising PSA and progression in bone with or without symptoms of disease. Still others will show soft tissue disease with or without osseous metastases, and others have visceral spread. The prognosis, which is highly variable, can be predicted using nomograms designed for the castration-resistant disease state.

    pdf5p konheokonmummim 03-12-2010 36 4   Download

  • Harrison's Internal Medicine Chapter 103.

    pdf5p thanhongan 07-12-2010 44 4   Download

  • The complement system (Chap. 308) consists of a group of serum proteins functioning as a cooperative, self-regulating cascade of enzymes that adhere to— and in some cases disrupt—the surface of invading organisms. Some of these surface-adherent proteins (e.g., C3b) can then act as opsonins for destruction of microbes by phagocytes. The later, "terminal" components (C7, C8, and C9) can directly kill some bacterial invaders (notably, many of the neisseriae) by forming a membrane attack complex and disrupting the integrity of the bacterial membrane, thus causing bacteriolysis.

    pdf5p thanhongan 07-12-2010 30 4   Download

  • Neurochemical Mechanisms in Disease P86. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 25 4   Download

  • Neurochemical Mechanisms in Disease P1. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 37 4   Download

  • Neurochemical Mechanisms in Disease P3. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 37 4   Download

  • Neurochemical Mechanisms in Disease P4. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 39 4   Download

  • Neurochemical Mechanisms in Disease P5. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 36 4   Download

  • Neurochemical Mechanisms in Disease P6. This volume of Advances in Neurobiology deals with the Neurochemistry of disease, with chapters covering both human diseases and animal “model” disorders. Specific diseases are covered in chapters on neurodegenerations such as Alzheimer’s and Parkinson's, on demyelinating diseases, on autism, and so on. This volume on Neurochemical Mechanisms in Disease strives to encourage more chemically based definitions of these and other diseases.

    pdf10p pretty26 10-12-2010 36 4   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản